About Kate Therapeutics
Kate Therapeutics is a private company based in San Diego, California, incorporated in 2020 in Delaware. It has reported $72,775,022 raised in three offerings on Form D since August 2024. Its chief executive is Kevin Forrest, Ph.D..
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 17, 2024 | Aug 7, 2024 | $21,775,022of $23.3M target | 8 | $2.7M | EquityRule 506(b) | Form D ↗ |
| Aug 31, 2021 | Aug 7, 2024 | $35,000,000fully sold | 5 | $7.0M | EquityRule 506(b) | Form D ↗ |
| Feb 5, 2021 | Aug 7, 2024 | $16,000,000fully sold | 1 | $16.0M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $72,775,022 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Kate Therapeutics's Form D filed Aug 7, 2024.
CD
Clare Ozawa, Ph.D.
Director
KD
Kevin Forrest, Ph.D.
Chief Executive Officer and director
BD
Beth Seidenberg, M.D.
Director